About SeLux Diagnostics
SeLux Diagnostics is a private company based in Charlestown, Massachusetts. It has reported $123,989,852 raised in six offerings on Form D since April 2018. Its chief executive is Steven Lufkin.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Feb 1, 2024 | Feb 13, 2024 | $40,000,000of $45.0M target | 9 | $4.4M | Debt, OptionsRule 506(b) | Form D ↗ |
| Feb 11, 2022 | Feb 28, 2022 | $48,175,947of $57.6M target | 25 | $1.9M | EquityRule 506(b) | Form D ↗ |
| Jun 7, 2021 | Jun 17, 2021 | $2,500,000of $7.5M target | 25 | $100K | Debt, OptionsRule 506(b) | Form D ↗ |
| Sep 18, 2020 | Oct 1, 2020 | $813,907of $1.7M target | 1 | $813K | Debt, OptionsRule 506(b) | Form D ↗ |
| Aug 29, 2019 | Sep 12, 2019 | $8,999,997fully sold | 27 | $333K | EquityRule 506(b) | Form D ↗ |
| Mar 28, 2018 | Apr 10, 2018 | $23,500,001of $25.0M target | 5 | $4.7M | EquityRule 506(b) | Form D ↗ |
| Total, six offerings | $123,989,852 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on SeLux Diagnostics's Form D filed Feb 13, 2024.
Earlier filings also listed Scott Yaphe (director, last listed Feb 2022), Jack Percoskie (executive officer, last listed Feb 2022), Vacic Alexander (executive officer, last listed Jun 2021), Stephen Zachary (director, last listed Jun 2021), Parker Cassidy (director, last listed Jun 2021) and Michael Rubin (director, last listed Apr 2018).